<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0186783</article-id>
<article-id pub-id-type="publisher-id">PONE-D-17-20769</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Vascular medicine</subject><subj-group><subject>Coronary heart disease</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Cardiology</subject><subj-group><subject>Coronary heart disease</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pharmaceutics</subject><subj-group><subject>Drug therapy</subject><subj-group><subject>Cardiovascular therapy</subject><subj-group><subject>ACE inhibitor therapy</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Population biology</subject><subj-group><subject>Population metrics</subject><subj-group><subject>Death rates</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Surgical and invasive medical procedures</subject><subj-group><subject>Cardiovascular procedures</subject><subj-group><subject>Coronary artery bypass grafting</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Vascular medicine</subject><subj-group><subject>Blood pressure</subject><subj-group><subject>Hypertension</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Endocrinology</subject><subj-group><subject>Endocrine disorders</subject><subj-group><subject>Diabetes mellitus</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Metabolic disorders</subject><subj-group><subject>Diabetes mellitus</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Surgical and invasive medical procedures</subject><subj-group><subject>Cardiovascular procedures</subject><subj-group><subject>Angioplasty</subject><subj-group><subject>Coronary angioplasty</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Cardiology</subject><subj-group><subject>Myocardial infarction</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Sex differences in long-term mortality among acute myocardial infarction patients: Results from the ISAR-RISK and ART studies</article-title>
<alt-title alt-title-type="running-head">Sex differences in AMI outcomes</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Ubrich</surname>
<given-names>Romy</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Barthel</surname>
<given-names>Petra</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Haller</surname>
<given-names>Bernhard</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Hnatkova</surname>
<given-names>Katerina</given-names>
</name>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Huster</surname>
<given-names>Katharina Maria</given-names>
</name>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Steger</surname>
<given-names>Alexander</given-names>
</name>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Müller</surname>
<given-names>Alexander</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Software</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Malik</surname>
<given-names>Marek</given-names>
</name>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
<xref ref-type="fn" rid="econtrib001"><sup>‡</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3692-5243</contrib-id>
<name name-style="western">
<surname>Schmidt</surname>
<given-names>Georg</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
<xref ref-type="fn" rid="econtrib001"><sup>‡</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Innere Medizin I, Klinikum rechts der Isar, Technische Universität München, Munich, Germany</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Institut für Medizinische Statistik und Epidemiologie, Technische Universität München, Munich, Germany</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>National Heart and Lung Institute, Imperial College, London, England</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>DZHK (German Centre for Cardiovascular Research), Partner site Munich Heart Alliance, Munich, Germany</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Bugiardini</surname>
<given-names>Raffaele</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>University of Bologna, ITALY</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="other" id="econtrib001">
<p>‡ These authors are senior authors on this work.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">gschmidt@tum.de</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>20</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>12</volume>
<issue>10</issue>
<elocation-id>e0186783</elocation-id>
<history>
<date date-type="received">
<day>31</day>
<month>5</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>6</day>
<month>10</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-year>2017</copyright-year>
<copyright-holder>Ubrich et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0186783"/>
<abstract>
<sec id="sec001">
<title>Background</title>
<p>Mortality rates in females who survived acute myocardial infarction (AMI) exceed those in males. Differences between sexes in age, cardiovascular risk factors and revascularization therapy have been proposed as possible reasons.</p>
</sec>
<sec id="sec002">
<title>Objective</title>
<p>To select sets of female and male patients comparable in respect of relevant risk factors in order to compare the sex-specific risk in a systematic manner.</p>
</sec>
<sec id="sec003">
<title>Methods</title>
<p>Data of the ISAR-RISK and ART studies were investigated. Patients were enrolled between 1996 and 2005 and suffered from AMI within 4 weeks prior to enrolment. Patients of each sex were selected with 1:1 equivalent age, previous AMI history, sinus-rhythm presence, hypertension, diabetes mellitus, smoking status, left ventricular ejection fraction (LVEF), and revascularization therapy. Survival times were compared between sex groups in the whole study cohort and in the matched cohort.</p>
</sec>
<sec id="sec004">
<title>Results</title>
<p>Of 3840 consecutive AMI survivors, 994 (25.9%) were females and 2846 (74.1%) were males. Females were older and suffered more frequently from hypertension and diabetes mellitus. In the whole cohort, females showed an increased mortality with a hazard ratio (HR) of 1.54 compared to males (p&lt;0.0001). The matched cohort comprised 802 patients of each sex and revealed a trend towards poorer survival in females (HR for female sex 1.14; p = 0.359). However, significant mortality differences with a higher risk in matched females was observed during the first year after AMI (HR = 1.61; p = 0.045) but not during the subsequent years.</p>
</sec>
<sec id="sec005">
<title>Conclusion</title>
<p>Matched sub-groups of post-AMI patients showed a comparable long-term mortality. However, a female excess mortality remained during first year after AMI and cannot be explained by differences in age, cardiovascular risk factors, and modes of acute treatment. Other causal factors, including clinical as well as psychological and social aspects, need to be considered. Female post-AMI patients should be followed more actively particularly during the first year after AMI.</p>
</sec>
</abstract>
<funding-group>
<funding-statement>The authors received no specific funding for this work.</funding-statement>
</funding-group>
<counts>
<fig-count count="6"/>
<table-count count="4"/>
<page-count count="17"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec006" sec-type="intro">
<title>Introduction</title>
<p>Survivors of acute myocardial infarction (AMI) are at increased risk of subsequent death due to, among others, re-infarction, arrhythmic events, or heart failure. In practically all existing reports [<xref ref-type="bibr" rid="pone.0186783.ref001">1</xref>–<xref ref-type="bibr" rid="pone.0186783.ref003">3</xref>], significantly higher crude follow-up mortality was observed in females compared to males. This has been attributed to the differences in age [<xref ref-type="bibr" rid="pone.0186783.ref004">4</xref>–<xref ref-type="bibr" rid="pone.0186783.ref007">7</xref>], comorbidities [<xref ref-type="bibr" rid="pone.0186783.ref004">4</xref>–<xref ref-type="bibr" rid="pone.0186783.ref006">6</xref>,<xref ref-type="bibr" rid="pone.0186783.ref008">8</xref>], symptom presentation [<xref ref-type="bibr" rid="pone.0186783.ref009">9</xref>–<xref ref-type="bibr" rid="pone.0186783.ref011">11</xref>] and pathophysiology of the underlying coronary artery disease [<xref ref-type="bibr" rid="pone.0186783.ref012">12</xref>–<xref ref-type="bibr" rid="pone.0186783.ref016">16</xref>]. Nevertheless, no solid data exist on the impact of these common sex differences on the post-AMI survival. In particular, data on the importance of the common sex differences are missing in patients treated according to contemporary standards including acute coronary interventions and guideline-based acute pharmacologic treatment.</p>
<p>Whilst the differences between females and males in the survival and severity of AMI have been the topic of a large number of investigations, direct comparisons between large groups of patients of both sexes carefully matched for a number of clinical characteristics are lacking. Such comparisons of case-by-case matched sex groups appear to be the most transparent method for confirming or eliminating the roles that different clinical and pathophysiological factors may play in the sex differences of post-AMI survival and prognosis. Having this in mind, we selected large sex-specific sub-groups of post-AMI patients case-by-case matched for potential confounders that included a majority of the factors that have previously been proposed as the sources of post-AMI sex differences [<xref ref-type="bibr" rid="pone.0186783.ref004">4</xref>–<xref ref-type="bibr" rid="pone.0186783.ref016">16</xref>]. This allowed us to investigate whether these confounders explain the known sex differences in post-AMI survival.</p>
</sec>
<sec id="sec007" sec-type="materials|methods">
<title>Methods</title>
<p>Patients of two previously reported prospective cohort studies, namely the ISAR-RISK [<xref ref-type="bibr" rid="pone.0186783.ref017">17</xref>] and ART [<xref ref-type="bibr" rid="pone.0186783.ref018">18</xref>] studies, were investigated. ISAR-RISK was a prospective cohort study aiming to prospectively validate heart rate turbulence in patients who had survived the first 30 days after initial hospitalization for an acute myocardial infarction [<xref ref-type="bibr" rid="pone.0186783.ref019">19</xref>]. ART was a prospective cohort study in the same kind of patients aiming to develop noninvasive risk predictors on the basis of 30-minute high resolution recordings of ECG, blood pressure and respiration [<xref ref-type="bibr" rid="pone.0186783.ref020">20</xref>–<xref ref-type="bibr" rid="pone.0186783.ref024">24</xref>].</p>
<p>ISAR-RISK patients were recruited between January 1996 and April 2000, ART patients between May 2000 and March 2005 at Klinikum rechts der Isar and Deutsches Herzzentrum München, both in Munich (Germany). The last follow-up for both studies was in May 2010. Study patients suffered from AMI within 4 weeks prior to enrolment. AMI was diagnosed if 2 of the following criteria were present: 1) chest pain lasting ≥20 minutes prior to admission, 2) creatine kinase-MB levels above double upper normal limit of our laboratory, 3) ST-Segment elevation of ≥0.1 mV in two or more limb leads and/or ≥0.2 mV in two or more contiguous precordial leads.</p>
<p>Revascularization was performed using percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG) or thrombolysis. Conservative revascularization therapy was performed in case of severe underlying diseases such as malignancies, diffuse obstructive coronary artery disease (CAD) and refusal of coronary angiography by the patient.</p>
<p>Both source studies were approved by the local ethics committee of Technische Universität München (Munich, Germany). All patients provided oral (ISAR-RISK) or written (ART) informed consent.</p>
<sec id="sec008">
<title>Clinical variables</title>
<p>On hospital admission, heart rate, blood pressure, serum creatinine and cardiac enzymes were measured and a standard 12-lead ECG recorded in all patients. Left ventricular ejection fraction (LVEF) was quantified by either echocardiography or angiography. Atrial fibrillation was diagnosed if present in the resting ECG at admission. Patients were considered to suffer from diabetes if they were already diagnosed and were receiving treatment or if their fasting blood glucose concentration repeatedly exceeded 11 mmol/L during the hospitalization for the index AMI. Patients were considered to suffer from hypertension if they were already diagnosed and were receiving treatment or if their arterial pressure repeatedly exceeded 140/90 mmHg during the hospitalization. Patients were considered to be smokers if they reported smoking at hospital admission.</p>
</sec>
<sec id="sec009">
<title>Follow-up and endpoints</title>
<p>Patients were followed-up every six months by clinical appointments. In case of non-attendance, patients were contacted personally or their status was assessed through their general practitioner. If the contact was lost, the local population registry provided a new address or confirmed the death of the patient. The primary endpoint was 5-year all-cause mortality.</p>
</sec>
<sec id="sec010">
<title>Composition of study cohort</title>
<p>A total of 4141 patients of the ISAR-RISK and the ART study were admitted to the hospital with AMI. Of these, 3854 patients survived the first 30 days after hospital admission. We further excluded 14 patients due to incomplete clinical baseline data. In the remaining cohort of 3840 patients, 994 (25.9%) were female and 2846 (74.1%) were male, respectively. In total, 29 (0.8%) patients were lost to follow-up (&lt;1 year) and were censored at their last attended clinical appointment.</p>
</sec>
<sec id="sec011">
<title>Statistics</title>
<p>Cohorts of 1:1 matched female and male patients were selected among all patients of the dataset to account for differences in known possible confounders of follow-up mortality allowing a comparison of survival times for females and males who are similar in relevant patient characteristics. For each female patient, a corresponding male patient was selected with corresponding age, LVEF, hypertension, diabetes mellitus, smoking status, non-sinus rhythm, previous AMI, and the category of revascularization therapy (i.e. PCI, CABG, thrombolysis, or “no intervention” which included patients without obstructive CAD and those treated conservatively in the presence of severe underlying disease, diffuse obstructive coronary artery disease, or coronary angiography refusal).</p>
<p>Only patients within the convex hull of the variables for females and males were considered to ensure similarity between matched female and male patients [<xref ref-type="bibr" rid="pone.0186783.ref025">25</xref>]. Within these patients, an exact match of the categorical variables (hypertension, diabetes mellitus, smoking status, non-sinus rhythm, previous AMI, and revascularization therapy) was performed. For quantitative measures, i.e. age and LVEF, a nearest-neighbor matching based on the propensity score [<xref ref-type="bibr" rid="pone.0186783.ref026">26</xref>] was used to find the best control match. Matching was performed using the R package “MatchIt” [<xref ref-type="bibr" rid="pone.0186783.ref027">27</xref>].</p>
<p>Continuous variables are presented as mean ± standard deviation (SD). Categorical data are presented as absolute frequencies and percentages. Group means were compared by two-tailed t-tests using Welch’s adaption for different group variances. Frequencies were compared by Chi-Square tests of Fisher exact tests. Survival curves were estimated by the Kaplan–Meier method and compared using the log-rank test. Confidence bands of the Kaplan-Meier curves were calculated using the bootstrap technique with 10,000 repetitions. Cox regression models were fit to the data to estimate hazard ratios with corresponding 95% confidence intervals (CI). Survival times were compared between females and males in the whole study cohort and in a cohort matched with regard to relevant confounders.</p>
<p>Additional survival analyses were performed to compare mortality risks for different time intervals. Specifically, separate analyses considered the sex survival differences during the first year after the index AMI, and the sex survival differences among patients who survived for at least one year after the index AMI.</p>
<p>A p-value of &lt;0.05 was considered as statistically significant. IBM SPSS Statistics 22.0 (IBM SPSS, Inc.) and R 3.2.2 (R Foundation for Statistical Computing, Vienna, Austria) were used for the statistical analyses.</p>
</sec>
</sec>
<sec id="sec012" sec-type="results">
<title>Results</title>
<sec id="sec013">
<title>Complete cohort</title>
<p><xref ref-type="table" rid="pone.0186783.t001">Table 1</xref> shows the clinical characteristics of the complete cohort at baseline hospitalization. Females were older and suffered more frequently from hypertension and diabetes mellitus. They were less often active smokers. A previous AMI in the past medical history was more often among males. Fewer females than males were in sinus rhythm. Males showed a significantly worse renal function than females. CK-levels at admission were significantly higher in males than in females. There were no significant LVEF differences between sexes.</p>
<table-wrap id="pone.0186783.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0186783.t001</object-id>
<label>Table 1</label> <caption><title>Patient characteristics in the complete cohort (n = 3,840) at baseline hospitalization.</title></caption>
<alternatives>
<graphic id="pone.0186783.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0186783.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="justify"/>
<th align="center">Females<break/>n = 994</th>
<th align="center">Males<break/>n = 2846</th>
<th align="center">P</th>
</tr>
</thead>
<tbody>
<tr>
<td align="justify"><bold>Clinical data</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Age (years), mean (SD)</td>
<td align="center">68.7 (11.9)</td>
<td align="center">61.0 (12.2)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left">Hypertension, n (%)</td>
<td align="center">745 (74.9)</td>
<td align="center">1853 (65.1)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left">Diabetes mellitus, n (%)</td>
<td align="center">255 (25.7)</td>
<td align="center">549 (19.3)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left">Smokers, n (%)</td>
<td align="center">272 (27.4)</td>
<td align="center">1542 (54.2)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left">Creatinine(mg/dl), mean (SD)</td>
<td align="center">1.2 (0.5)</td>
<td align="center">1.3 (0.2)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left">Previous AMI, n (%)</td>
<td align="center">102 (10.3)</td>
<td align="center">386 (13.6)</td>
<td align="center">0.008</td>
</tr>
<tr>
<td align="left">Non-SR, n (%)</td>
<td align="center">79 (7.9)</td>
<td align="center">166 (5.8)</td>
<td align="center">0.023</td>
</tr>
<tr>
<td align="left">CK max (U/l), mean (SD)</td>
<td align="center">1526 (1583)</td>
<td align="center">2017 (2385)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left">LVEF (%),mean (SD)</td>
<td align="center">52.6 (13.4)</td>
<td align="center">52.0 (13.0)</td>
<td align="center">0.177</td>
</tr>
<tr>
<td align="left">Coronary angiography, n (%)</td>
<td align="center">986 (99.2)</td>
<td align="center">2836 (99.6)</td>
<td align="center">0.125</td>
</tr>
<tr>
<td align="left">Non-obstructive CAD, n (%)</td>
<td align="center">52 (5.2)</td>
<td align="center">69 (2.4)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left">One-vessel CAD, n (%)</td>
<td align="center">357 (35.9)</td>
<td align="center">924 (32.5)</td>
<td align="center">0.052</td>
</tr>
<tr>
<td align="left">Two-vessel CAD, n (%)</td>
<td align="center">258 (26.0)</td>
<td align="center">790 (27.8)</td>
<td align="center">0.291</td>
</tr>
<tr>
<td align="left">Three-vessel CAD, n (%)</td>
<td align="center">327 (32.9)</td>
<td align="center">1063 (37.4)</td>
<td align="center">0.013</td>
</tr>
<tr>
<td align="justify"><bold>Therapy</bold></td>
<td align="right"/>
<td align="right"/>
<td align="right"/>
</tr>
<tr>
<td align="left">PCI, n (%)</td>
<td align="right">852 (85.7)</td>
<td align="right">2589 (91.0)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left">CABG, n (%)</td>
<td align="right">28 (2.8)</td>
<td align="right">84 (3.0)</td>
<td align="center">0.914</td>
</tr>
<tr>
<td align="left">Thrombolysis n (%)</td>
<td align="right">24 (2.4)</td>
<td align="right">60 (2.1)</td>
<td align="center">0.658</td>
</tr>
<tr>
<td align="left">Conservative, n (%)</td>
<td align="right">90 (9.1)</td>
<td align="right">113 (4.0)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left">ASS, n (%)</td>
<td align="right">964 (97.0)</td>
<td align="right">2759 (96.9)</td>
<td align="center">1.000</td>
</tr>
<tr>
<td align="left">Betablockers, n (%)</td>
<td align="right">921 (92.7)</td>
<td align="right">2609 (91.7)</td>
<td align="center">0.362</td>
</tr>
<tr>
<td align="left">ACE inhibitors, n (%)</td>
<td align="right">880 (88.5)</td>
<td align="right">2550 (89.6)</td>
<td align="center">0.379</td>
</tr>
<tr>
<td align="left">Statins, n (%)</td>
<td align="right">829 (83.4)</td>
<td align="right">2414 (81.0)</td>
<td align="center">0.311</td>
</tr>
<tr>
<td align="left">Diuretics, n (%)</td>
<td align="right">472 (47.5)</td>
<td align="right">1195 (42.0)</td>
<td align="center">0.003</td>
</tr>
<tr>
<td align="justify"><bold>Mortality</bold></td>
<td align="right"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="left">5-year all-cause, n (%)</td>
<td align="right">175 (17.6)</td>
<td align="center">337 (11.8)</td>
<td align="center">&lt;0.0001</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>ACE inhibitor: angiotensin-converting enzyme inhibitor, AMI: myocardial infarction, ASS: acetylsalicylic acid, CABG: coronary artery bypass grafting, CAD: coronary artery disease, CK max: maximal level of creatine kinase, LVEF: left ventricular ejection fraction, PCI: percutaneous coronary intervention, SD: standard deviation, SR: sinus rhythm</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Coronary angiography was performed in 99.2% and 99.6% of female and male patients, respectively. A non-obstructive CAD was significantly more often noted in females than in males. Accordingly, females were more frequently treated conservatively regarding PCI revascularization. Males showed a significantly higher rate of three-vessel CAD. Thrombolysis and CABG were infrequent in both groups without significant differences.</p>
<p>Drug therapy after AMI with acetylsalicylic acid (ASS), betablockers, angiotensin-converting enzyme inhibitors (ACE-inhibitors) and statins did not differ significantly between sexes. The use of diuretics was more frequent in females.</p>
<p>The probability of death of any cause was significantly higher in females during the five years of follow-up (17.6% vs. 11.8%; HR for female sex 1.54; CI 1.28–1.85; p&lt;0.0001; <xref ref-type="fig" rid="pone.0186783.g001">Fig 1</xref>).</p>
<fig id="pone.0186783.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0186783.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Probabilities of death stratified by sex in the entire study cohort.</title>
<p>Red and blue lines and bands correspond to females and males, respectively. The dark shaded and light shaded areas correspond to inter-quartile bands and 90% confidence bands of the Kaplan-Meier probability curves, respectively. Numbers of patients at risk are shown below the graph in colors corresponding to the probability curves. CI– 95% confidence interval; HR–hazard ratio of females vs. males.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0186783.g001" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec014">
<title>Matched cohort</title>
<p>The matched cohort included 1604 patients; 802 patients of either sex. <xref ref-type="table" rid="pone.0186783.t002">Table 2</xref> presents the clinical characteristics of the matched cohort. Clinical parameters regarding cardiovascular risk factors and revascularization therapy were equally distributed between the sexes with age nearly balanced (67.5 years in females versus 67.0 years in males, p = 0.153). Serum creatinine was significantly higher in males than in females. No statistically significant differences were observed with respect of pharmaceutical therapy with the exception of ACE inhibitors which were less often administered in females (89.7% versus 92.8%, p = 0.034). Almost all patients underwent coronary angiography (≥99.5%) in both sexes. The prevalence of non-obstructive CAD was non-significantly more frequent in females (3.4% in females versus 2.0% in males, p = 0.122). Prevalence of one-vessel CAD was significantly more often in females, a three-vessel CAD predominated in males.</p>
<table-wrap id="pone.0186783.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0186783.t002</object-id>
<label>Table 2</label> <caption><title>Clinical characteristics in the matched cohort (n = 1,604).</title></caption>
<alternatives>
<graphic id="pone.0186783.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0186783.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="justify"/>
<th align="center">Females<break/>n = 802</th>
<th align="center">Males<break/>n = 802</th>
<th align="center">P</th>
</tr>
</thead>
<tbody>
<tr>
<td align="justify"><bold>Clinical data</bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Age (years), SD</td>
<td align="center">67.5 (11.1)</td>
<td align="center">67.0 (10.7)</td>
<td align="center">0.153</td>
</tr>
<tr>
<td align="left">Hypertension, n (%)</td>
<td align="center">613 (76.4)</td>
<td align="center">613 (76.4)</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">Diabetes mellitus, n (%)</td>
<td align="center">192 (23.9)</td>
<td align="center">192 (23.9)</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">Smokers, n (%)</td>
<td align="center">226 (28.2)</td>
<td align="center">226 (28.2)</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">Creatinine(mg/dl),mean (SD)</td>
<td align="center">1.1 (0.5)</td>
<td align="center">1.3 (0.4)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left">Previous AMI, n (%)</td>
<td align="center">50 (6.2)</td>
<td align="center">50 (6.2)</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">Non-SR, n (%)</td>
<td align="center">34 (4.2)</td>
<td align="center">34 (4.2)</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">CK max (U/l), mean (SD)</td>
<td align="center">1580 (1612)</td>
<td align="center">1819 (2232)</td>
<td align="center">0.008</td>
</tr>
<tr>
<td align="left">LVEF (%), SD</td>
<td align="center">53.4 (11.7)</td>
<td align="center">53.4 (11.3)</td>
<td align="center">0.939</td>
</tr>
<tr>
<td align="left">Coronary angiography, n (%)</td>
<td align="center">798 (99.5)</td>
<td align="center">799 (99.6)</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">Non-obstructive CAD, n (%)</td>
<td align="center">27 (3.4)</td>
<td align="center">16 (2.0)</td>
<td align="center">0.122</td>
</tr>
<tr>
<td align="left">One-vessel CAD, n (%)</td>
<td align="center">310 (38.7)</td>
<td align="center">239 (29.8)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left">Two-vessel CAD, n (%)</td>
<td align="center">222 (27.7)</td>
<td align="center">228 (28.4)</td>
<td align="center">0.781</td>
</tr>
<tr>
<td align="left">Three-vessel CAD, n (%)</td>
<td align="center">243 (30.3)</td>
<td align="center">319 (39.8)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="justify"><bold>Therapy</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="left">PCI, n (%)</td>
<td align="center">758 (94.5)</td>
<td align="center">761(94.9)</td>
<td align="center">0.824</td>
</tr>
<tr>
<td align="left">CABG, n (%)</td>
<td align="center">6 (0.7)</td>
<td align="center">7 (0.9)</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">Thrombolysis, n (%)</td>
<td align="center">3 (0.4)</td>
<td align="center">3 (0.4)</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">Conservative, n (%)</td>
<td align="center">35 (4.4)</td>
<td align="center">31 (3.9)</td>
<td align="center">0.706</td>
</tr>
<tr>
<td align="left">ASS, n (%)</td>
<td align="center">781 (97.4)</td>
<td align="center">784 (97.8)</td>
<td align="center">0.746</td>
</tr>
<tr>
<td align="left">Betablockers, n (%)</td>
<td align="center">753 (93.9)</td>
<td align="center">741 (92.4)</td>
<td align="center">0.277</td>
</tr>
<tr>
<td align="left">ACE inhibitors, n (%)</td>
<td align="center">719 (89.7)</td>
<td align="center">744 (92.8)</td>
<td align="center">0.034</td>
</tr>
<tr>
<td align="left">Statins, n (%)</td>
<td align="center">677 (84.4)</td>
<td align="center">697 (86.9)</td>
<td align="center">0.176</td>
</tr>
<tr>
<td align="left">Diuretics, n (%)</td>
<td align="center">361 (45.0)</td>
<td align="center">348 (43.4)</td>
<td align="center">0.546</td>
</tr>
<tr>
<td align="justify"><bold>Mortality</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="left">5-year all-cause, n (%)</td>
<td align="center">109 (13.6)</td>
<td align="center">94 (11.7)</td>
<td align="center">0.293</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p>Matching was performed according to the composite of age, LVEF, hypertension, diabetes mellitus, smoking status, non-sinus rhythm, previous AMI and revascularization therapy. ACE inhibitor: angiotensin-converting enzyme inhibitor, AMI: myocardial infarction, ASS: acetylsalicylic acid, CABG: coronary artery bypass grafting, CAD: coronary artery disease, CK max: maximal level of creatine kinase, LVEF: left ventricular ejection fraction, PCI: percutaneous coronary intervention, SD: standard deviation, SR: sinus rhythm</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Over the entire follow-up period of five years, the mortality rates of female and male patients of the matched cohort did not differ significantly although a trend towards a poorer survival in females was observed (13.6% versus 11.7%; HR for female sex 1.14; CI 0.86–1.49; p = 0.359; <xref ref-type="fig" rid="pone.0186783.g002">Fig 2</xref>). However, when restricting the analysis to the first year of follow-up, female patients had a significantly worse outcome (mortality of 5.7% in females versus 3.6% in males; HR 1.61; CI 1.01–2.56; p = 0.045; <xref ref-type="fig" rid="pone.0186783.g003">Fig 3</xref>). The mortality between years 2 and 5 was practically identical between both sexes (8.1% in men versus 7.9% in women; HR 0.93; CI 0.66–1.32; p = 0.693; <xref ref-type="fig" rid="pone.0186783.g004">Fig 4</xref>).</p>
<fig id="pone.0186783.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0186783.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Probabilities of death stratified by sex in the cohort of matched patients.</title>
<p>Red and blue lines and bands correspond to females and males, respectively. The dark shaded and light shaded areas correspond to inter-quartile bands and 90% confidence bands of the Kaplan-Meier probability curves, respectively. Light violet areas show the overlap of the 90% confidence bands, dark violet areas show the overlap of the inter-quartile bands of one of the probability curves with the 90% confidence band of the other curve. Numbers of patients at risk are shown below the graph in colors corresponding to the probability curves. CI– 95% confidence interval; HR–hazard ratio of females vs. males.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0186783.g002" xlink:type="simple"/>
</fig>
<fig id="pone.0186783.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0186783.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Probabilities of death stratified by sex in the sex-matched cohort during the first year after the index infarction.</title>
<p>See <xref ref-type="fig" rid="pone.0186783.g002">Fig 2</xref> for details.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0186783.g003" xlink:type="simple"/>
</fig>
<fig id="pone.0186783.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0186783.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Probabilities of death stratified by sex in the sex-matched cohort between the second and fifth year after the index infarction.</title>
<p>See <xref ref-type="fig" rid="pone.0186783.g002">Fig 2</xref> for details.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0186783.g004" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec015">
<title>Comparison between unmatched and matched females</title>
<p>No matching male counterpart was found for 192 females (19.3% of all female patients), because it was impossible to find absolute correspondence in all of the matching criteria. <xref ref-type="table" rid="pone.0186783.t003">Table 3</xref> shows the comparison between unmatched and matched females. There were substantial and statistically significant differences in many of the characteristics with the unmatched females being markedly older, suffering more frequently from diabetes mellitus and hypertension and showing a significantly higher rate of non-obstructive CAD (13.0% in unmatched females versus 3.4% in matched females, p&lt;0.001). Rates of revascularization by PCI were strikingly less frequent in unmatched females compared to matched females (49.0% versus 94.5%, p&lt;0.001) and unmatched females were more often treated conservatively (28.6% versus 4.4%, p&lt;0.001).</p>
<table-wrap id="pone.0186783.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0186783.t003</object-id>
<label>Table 3</label> <caption><title>Patient characteristics of unmatched and matched females (n = 994).</title></caption>
<alternatives>
<graphic id="pone.0186783.t003g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0186783.t003" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="justify"/>
<th align="center">Unmatched Females<break/>n = 192</th>
<th align="center">Matched Females<break/>n = 802</th>
<th align="center">P</th>
</tr>
</thead>
<tbody>
<tr>
<td align="justify"><bold>Clinical data</bold></td>
<td align="left"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="left">Age (years), mean (SD)</td>
<td align="center">73.7 (13.9)</td>
<td align="center">67.5 (11.1)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left">Hypertension, n (%)</td>
<td align="center">132 (68.8)</td>
<td align="center">613 (76.4)</td>
<td align="center">0.034</td>
</tr>
<tr>
<td align="left">Diabetes mellitus, n (%)</td>
<td align="center">63 (32.8)</td>
<td align="center">192 (23.9)</td>
<td align="center">0.015</td>
</tr>
<tr>
<td align="left">Smokers, n (%)</td>
<td align="center">46 (24.0)</td>
<td align="center">226 (28.2)</td>
<td align="center">0.276</td>
</tr>
<tr>
<td align="left">Creatinine(mg/dl), mean (SD)</td>
<td align="center">1.21 (0.52)</td>
<td align="center">1.10 (0.52)</td>
<td align="center">0.005</td>
</tr>
<tr>
<td align="left">Previous AMI, n (%)</td>
<td align="center">52 (27.1)</td>
<td align="center">50 (6.2)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left">Non-SR, n (%)</td>
<td align="center">45 (23.4)</td>
<td align="center">34 (4.2)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left">CK max (U/l), mean (SD)</td>
<td align="center">1300 (1443)</td>
<td align="center">1580 (1612)</td>
<td align="center">0.011</td>
</tr>
<tr>
<td align="left">LVEF (%),mean (SD)</td>
<td align="center">49.3 (18.8)</td>
<td align="center">53.4 (11.7)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left">Coronary angiography, n (%)</td>
<td align="center">188 (97.9)</td>
<td align="center">798 (99.5)</td>
<td align="center">0.079</td>
</tr>
<tr>
<td align="left">Non-obstructive CAD, n (%)</td>
<td align="center">25 (13.0)</td>
<td align="center">27 (3.4)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left">One-vessel CAD, n (%)</td>
<td align="center">47 (24.5)</td>
<td align="center">310 (38.7)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left">Two-vessel CAD, n (%)</td>
<td align="center">36 (18.8)</td>
<td align="center">222 (27.7)</td>
<td align="center">0.015</td>
</tr>
<tr>
<td align="left">Three-vessel CAD, n (%)</td>
<td align="center">84 (43.8)</td>
<td align="center">243 (30.3)</td>
<td align="center">0.001</td>
</tr>
<tr>
<td align="justify"><bold>Therapy</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="left">PCI, n (%)</td>
<td align="center">94 (49.0)</td>
<td align="center">758 (94.5)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left">CABG, n (%)</td>
<td align="center">22 (11.5)</td>
<td align="center">6 (0.7)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left">Thrombolysis n (%)</td>
<td align="center">21 (10.9)</td>
<td align="center">3 (0.4)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left">Conservative, n (%)</td>
<td align="center">55 (28.6)</td>
<td align="center">35 (4.4)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left">ASS, n (%)</td>
<td align="center">183 (95.3)</td>
<td align="center">781 (97.4)</td>
<td align="center">0.204</td>
</tr>
<tr>
<td align="left">Betablockers, n (%)</td>
<td align="center">168 (87.5)</td>
<td align="center">753 (93.9)</td>
<td align="center">0.004</td>
</tr>
<tr>
<td align="left">ACE inhibitors, n (%)</td>
<td align="center">161 (83.9)</td>
<td align="center">719 (89.7)</td>
<td align="center">0.033</td>
</tr>
<tr>
<td align="left">Statins, n (%)</td>
<td align="center">152 (79.2)</td>
<td align="center">677 (84.4)</td>
<td align="center">0.099</td>
</tr>
<tr>
<td align="left">Diuretics, n (%)</td>
<td align="center">111 (57.8)</td>
<td align="center">361 (45.0)</td>
<td align="center">0.002</td>
</tr>
<tr>
<td align="justify"><bold>Mortality</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="left">5-year all-cause, n (%)</td>
<td align="center">66 (34.4)</td>
<td align="center">109 (13.6)</td>
<td align="center">&lt;0.001</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001"><p>ACE inhibitor: angiotensin-converting enzyme inhibitor, AMI: myocardial infarction, ASS: acetylsalicylic acid, CABG: coronary artery bypass grafting, CAD: coronary artery disease, CK max: maximal level of creatine kinase, LVEF: left ventricular ejection fraction, PCI: percutaneous coronary intervention, SD: standard deviation, SR: sinus rhythm</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Not surprisingly, the survival of the unmatched females was also substantially poorer compared to matched females (5-year mortality of 34.4% versus 13.6%; HR = 2.89; CI 2.13–3.93; p = &lt;0.0001; <xref ref-type="fig" rid="pone.0186783.g005">Fig 5</xref>).</p>
<fig id="pone.0186783.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0186783.g005</object-id>
<label>Fig 5</label>
<caption>
<title>Probabilities of death comparing females included and not included in the sex-matched cohort.</title>
<p>Red and brown lines and bands correspond to females included (n = 802) and not included (n = 192) in the sex-matched cohort, respectively. The dark shaded and light shaded areas correspond to inter-quartile bands and 90% confidence bands of the Kaplan-Meier probability curves, respectively. Light grey areas show the overlap of the 90% confidence bands, dark grey areas show the overlap of the inter-quartile bands of one of the probability curves with the 90% confidence band of the other curve. Numbers of patients at risk are shown below the graph in colors corresponding to the probability curves. CI– 95% confidence interval; HR–hazard ratio of females not included vs. included in the sex-matched cohort.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0186783.g005" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec016">
<title>Comparison between unmatched and matched males</title>
<p>Contrary to females, comparison between unmatched and matched males reveals a significant younger age and a lower prevalence of hypertension and diabetes mellitus for the unmatched patients. There was no statistical significant difference regarding the non-obstructive or obstructive CAD between these groups. <xref ref-type="table" rid="pone.0186783.t004">Table 4</xref> shows the comparison between unmatched and matched males.</p>
<table-wrap id="pone.0186783.t004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0186783.t004</object-id>
<label>Table 4</label> <caption><title>Patient characteristics of unmatched and matched males (n = 2846).</title></caption>
<alternatives>
<graphic id="pone.0186783.t004g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0186783.t004" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="justify"/>
<th align="center">Unmatched Males<break/>n = 2044</th>
<th align="center">Matched Males<break/>n = 802</th>
<th align="center">P</th>
</tr>
</thead>
<tbody>
<tr>
<td align="justify"><bold>Clinical data</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="left">Age (years), mean (SD)</td>
<td align="center">58.7 (11.9)</td>
<td align="center">67.0 (10.7)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left">Hypertension, n (%)</td>
<td align="center">1240 (60.6)</td>
<td align="center">613 (76.4)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left">Diabetes mellitus, n (%)</td>
<td align="center">357 (17.5)</td>
<td align="center">192 (23.9)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left">Smokers, n (%)</td>
<td align="center">1316 (64.4)</td>
<td align="center">226 (28.2)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left">Creatinine(mg/dl), mean (SD)</td>
<td align="center">1.22 (0.42)</td>
<td align="center">1.25 (0.41)</td>
<td align="center">0.008</td>
</tr>
<tr>
<td align="left">Previous AMI, n (%)</td>
<td align="center">336 (16.4)</td>
<td align="center">50 (6.2)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left">Non-SR, n (%)</td>
<td align="center">132 (6.5)</td>
<td align="center">34 (4.2)</td>
<td align="center">0.029</td>
</tr>
<tr>
<td align="left">CK max (U/l), mean (SD)</td>
<td align="center">2095 (2438)</td>
<td align="center">1819 (2232)</td>
<td align="center">0.016</td>
</tr>
<tr>
<td align="left">LVEF (%),mean (SD)</td>
<td align="center">51.5 (13.6)</td>
<td align="center">53.4 (11.3)</td>
<td align="center">0.008</td>
</tr>
<tr>
<td align="left">Coronary angiography, n (%)</td>
<td align="center">2037 (99.7)</td>
<td align="center">799 (99.6)</td>
<td align="center">1.0</td>
</tr>
<tr>
<td align="left">Non-obstructive CAD, n (%)</td>
<td align="center">53 (2.6)</td>
<td align="center">16 (2.0)</td>
<td align="center">0.425</td>
</tr>
<tr>
<td align="left">One-vessel CAD, n (%)</td>
<td align="center">685 (33.5)</td>
<td align="center">239 (29.8)</td>
<td align="center">0.063</td>
</tr>
<tr>
<td align="left">Two-vessel CAD, n (%)</td>
<td align="center">562 (27.5)</td>
<td align="center">228 (28.4)</td>
<td align="center">0.650</td>
</tr>
<tr>
<td align="left">Three-vessel CAD, n (%)</td>
<td align="center">744 (36.4)</td>
<td align="center">319 (39.8)</td>
<td align="center">0.103</td>
</tr>
<tr>
<td align="justify"><bold>Therapy</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="left">PCI, n (%)</td>
<td align="center">1828 (89.4)</td>
<td align="center">761(94.9)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left">CABG, n (%)</td>
<td align="center">77 (3.8)</td>
<td align="center">7 (0.9)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left">Thrombolysis n (%)</td>
<td align="center">57 (2.8)</td>
<td align="center">3 (0.4)</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left">Conservative, n (%)</td>
<td align="center">82 (4.0)</td>
<td align="center">31 (3.9)</td>
<td align="center">0.942</td>
</tr>
<tr>
<td align="left">ASS, n (%)</td>
<td align="center">1975 (96.6)</td>
<td align="center">784 (97.8)</td>
<td align="center">0.145</td>
</tr>
<tr>
<td align="left">Betablockers, n (%)</td>
<td align="center">1868 (91.4)</td>
<td align="center">741 (92.4)</td>
<td align="center">0.425</td>
</tr>
<tr>
<td align="left">ACE inhibitors, n (%)</td>
<td align="center">1806 (88.4)</td>
<td align="center">744 (92.8)</td>
<td align="center">0.001</td>
</tr>
<tr>
<td align="left">Statins, n (%)</td>
<td align="center">1717 (84.0)</td>
<td align="center">697 (86.9)</td>
<td align="center">0.059</td>
</tr>
<tr>
<td align="left">Diuretics, n (%)</td>
<td align="center">847 (41.4)</td>
<td align="center">348 (43.4)</td>
<td align="center">0.364</td>
</tr>
<tr>
<td align="justify"><bold>Mortality</bold></td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
</tr>
<tr>
<td align="left">5-year all-cause, n (%)</td>
<td align="center">243 (11.9)</td>
<td align="center">94 (11.7)</td>
<td align="center">0.952</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t004fn001"><p>ACE inhibitor: angiotensin-converting enzyme inhibitor, AMI: myocardial infarction, ASS: acetylsalicylic acid, CABG: coronary artery bypass grafting, CAD: coronary artery disease, CK max: maximal level of creatine kinase, LVEF: left ventricular ejection fraction, PCI: percutaneous coronary intervention, SD: standard deviation, SR: sinus rhythm</p></fn>
</table-wrap-foot>
</table-wrap>
<p>In contrast to females, survival rates between unmatched and matched males were similar (11.9% versus 11.7%; HR = 0.98; CI 0.77–1.24; p = 0.854; <xref ref-type="fig" rid="pone.0186783.g006">Fig 6</xref>). Note that also the survival rates between matched and unmatched males were also similar during the first year after the index AMI (p = 0.172, detailed data not shown).</p>
<fig id="pone.0186783.g006" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0186783.g006</object-id>
<label>Fig 6</label>
<caption>
<title>Probabilities of death comparing males included and not included in the sex-matched cohort.</title>
<p>Light blue and dark blue lines and bands correspond to males included (n = 802) and not included (n = 2044) in the sex-matched cohort, respectively. Further explanations correspond to <xref ref-type="fig" rid="pone.0186783.g005">Fig 5</xref>. HR–hazard ratio of men not included vs. included in the sex-matched cohort.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0186783.g006" xlink:type="simple"/>
</fig>
</sec>
</sec>
<sec id="sec017" sec-type="conclusions">
<title>Discussion</title>
<p>In agreement with previous studies [<xref ref-type="bibr" rid="pone.0186783.ref001">1</xref>,<xref ref-type="bibr" rid="pone.0186783.ref004">4</xref>,<xref ref-type="bibr" rid="pone.0186783.ref028">28</xref>–<xref ref-type="bibr" rid="pone.0186783.ref031">31</xref>], female post-infarction patients included in our prospective cohort study had a significantly higher mortality risk compared to males. Our data agree with previous explanations of this difference by female patients being older [<xref ref-type="bibr" rid="pone.0186783.ref004">4</xref>–<xref ref-type="bibr" rid="pone.0186783.ref007">7</xref>], having a higher prevalence of comorbidities such as hypertension and diabetes [<xref ref-type="bibr" rid="pone.0186783.ref004">4</xref>–<xref ref-type="bibr" rid="pone.0186783.ref006">6</xref>,<xref ref-type="bibr" rid="pone.0186783.ref008">8</xref>] and of non-obstructive CAD [<xref ref-type="bibr" rid="pone.0186783.ref012">12</xref>–<xref ref-type="bibr" rid="pone.0186783.ref016">16</xref>], being subject to a less invasive diagnostic [<xref ref-type="bibr" rid="pone.0186783.ref006">6</xref>,<xref ref-type="bibr" rid="pone.0186783.ref032">32</xref>] or therapeutic approach [<xref ref-type="bibr" rid="pone.0186783.ref006">6</xref>,<xref ref-type="bibr" rid="pone.0186783.ref033">33</xref>–<xref ref-type="bibr" rid="pone.0186783.ref036">36</xref>] as well as by the composite of different variables [<xref ref-type="bibr" rid="pone.0186783.ref037">37</xref>]. Indeed, comparison of Figs <xref ref-type="fig" rid="pone.0186783.g005">5</xref> and <xref ref-type="fig" rid="pone.0186783.g006">6</xref> shows that while the subgroup of sex-matched males was, in terms of post-AMI survival, representative of all the males, this was not the case for females. Not only the previously reported risk factors but also their clinically more severe combinations are more frequent among females compare to males.</p>
<p>Aim of the matching analysis was to generate sets of females and males that were comparable regarding relevant risk factors in order to compare the sex-specific risk in a fair and systematic manner.</p>
<p>Importantly—as a result of the strict matching process—the oldest and sickest females were excluded from the matched cohort. Unmatched females had a higher risk factor burden, suffered more often from non-obstructive CAD, and had an almost 3-fold increase in 5-year mortality compared to those for whom a corresponding male patient was found.</p>
<p>In a matched cohort with the potentially influencing variables balanced, all-cause mortality during 5-year follow-up did not differ significantly between sexes over the whole 5-year follow-up period. However, we observed a significantly increased mortality risk in females during the first year of follow-up (HR 1.61; p = 0.045). Since the matched criteria can be excluded as reasons for the observed sex-specific mortality difference, other clinical and non-clinical aspects need to be considered as possible explanations for the observed mortality difference.</p>
<p>From the clinical point of view, factors such as time to PCI or thrombolysis as well as different pathologies leading to infarction such as dynamic obstruction, endothelial dysfunction or stress cardiomyopathy need to be taken into account. We could not evaluate all these possibilities in our matching analysis since the matching sub-groups would become too small and non-representative.</p>
<p>When recruitment for the ISAR-RISK [<xref ref-type="bibr" rid="pone.0186783.ref017">17</xref>] and ART [<xref ref-type="bibr" rid="pone.0186783.ref018">18</xref>] studies was initiated, distinctive knowledge about the mortality impact of the symptoms-to-balloon time [<xref ref-type="bibr" rid="pone.0186783.ref038">38</xref>–<xref ref-type="bibr" rid="pone.0186783.ref040">40</xref>] was only evolving. Consequently, these data were not routinely collected. We cannot exclude their influence on the observed mortality difference. However, we assume that treatment in females could not have been significantly delayed, as higher ischemic burden would have led to significantly increased CK-levels or impaired left ventricular function compared to males, which was not the case in the matched cohort.</p>
<p>Former studies reported higher renal dysfunction in female ST-elevation myocardial infarction (STEMI) patients and detected equal increment of mortality in both sexes in case of renal impairment [<xref ref-type="bibr" rid="pone.0186783.ref041">41</xref>,<xref ref-type="bibr" rid="pone.0186783.ref042">42</xref>]. In our cohort, males showed a decreased renal function compared to females in both the total and matched cohort. Still, female mortality exceeded that of males. This observation is even more surprising in this context.</p>
<p>Leaving the clinical aspects aside, a number of studies revealed non-clinical sex-specific factors such as socioeconomic status or depression contributing to worse outcome in female post-AMI patients [<xref ref-type="bibr" rid="pone.0186783.ref043">43</xref>–<xref ref-type="bibr" rid="pone.0186783.ref045">45</xref>]. Compared to males, female AMI survivors present more often with psychological stress. They have lower scores on mental health status [<xref ref-type="bibr" rid="pone.0186783.ref046">46</xref>], show a greater functional decline and poorer health-related quality of life [<xref ref-type="bibr" rid="pone.0186783.ref047">47</xref>–<xref ref-type="bibr" rid="pone.0186783.ref053">53</xref>] and also suffer more frequently from depression [<xref ref-type="bibr" rid="pone.0186783.ref054">54</xref>]. At the same time, psychosocial factors are known to play an important role in post-AMI recovery and to predict 1-year cardiac mortality, independent of the severity of cardiac disease [<xref ref-type="bibr" rid="pone.0186783.ref045">45</xref>,<xref ref-type="bibr" rid="pone.0186783.ref046">46</xref>,<xref ref-type="bibr" rid="pone.0186783.ref051">51</xref>]. Correspondingly, family life status is known to influence post-AMI survival [<xref ref-type="bibr" rid="pone.0186783.ref045">45</xref>,<xref ref-type="bibr" rid="pone.0186783.ref055">55</xref>,<xref ref-type="bibr" rid="pone.0186783.ref056">56</xref>]. As we did not have the data to assess social status, marital status, quality of life or presence of depressive symptoms in this cohort, we cannot exclude these non-clinical factors from a partial influence on the detected mortality difference during the first year after AMI.</p>
<p>Equally importantly, autonomic function might play a role in respect of post-AMI mortality rates independently of clinical and social sex-specific differences. Measures of autonomic regulation processes have been proven as independent and useful risk stratification parameters [<xref ref-type="bibr" rid="pone.0186783.ref057">57</xref>]. However, studies investigating the impact of sex-dependent differences in cardiac autonomous nervous system on the outcome after AMI are rare and have been so far inconclusive.</p>
<p>Finally, the possibility that the early divergence in mortality risk in our matched cohort is due to a play of chance cannot be entirely excluded.</p>
<p>Despite the number of the confounders that we could not have included in the matching process, our observations have important clinical implications. The excess mortality among females in the matched subgroups was observed during first year after the index AMI. Female AMI patients should therefore be followed more actively in the early post-AMI stages with more frequent follow-up clinical assessments at least in the first year after the event. Attention should be given to psychological and psycho-social factors in female patients with appropriate referrals to relevant specialists. Psychological support through specialists’ sessions and/or patient self-supporting groups for inter-patient communication and discussion should be considered.</p>
<p>Since the confounders that we have used for matching the sex groups are frequently used in guidelines and consensus proposals for post-AMI clinical care, our results also suggest that it is not fully appropriate to rely on evidence obtained in studies of predominantly male patients when treating female patients. Separate studies in female patients are needed to confirm whether the male-based evidence is appropriate or whether different guideline criteria are needed for both sexes.</p>
<sec id="sec018">
<title>Limitations</title>
<p>Several limitations of our study need to be considered. In the original ISAR-Risk and ART studies, no detailed information was collected about clinical data regarding symptoms-to-balloon-time or coronary pathology including endothelial dysfunction causing the myocardial infarction. Apart from smoking, we are unable to include any data on pre-AMI lifestyles. Also, socioeconomic aspects, family support and the prevalence of depression were not assessed. We can only assume that these factors had substantial impact on mortality rates in the matched cohort, but cannot exclude other so far unknown factors.</p>
<p>Although the identification of the 1:1 matching groups was performed using previously proposed factors contributing to the survival differences, some differences between the matched groups could not have been eliminated. Not only were the women in the case-matched analysis less frequently treated with ACE inhibitors, they were also tiny bit older and suffered more frequently from a non-obstructive CAD. It was impossible to include pharmacological treatments (including that by ACE inhibitors) into the matching procedure, as the matched groups would have been too small and non-representative.</p>
<p>As risk profiles between sexes differed such substantially—especially regarding age—it was impossible to find a female-male match in one fifth of female patients. More liberal matching criteria could have been considered but this would have led to groups differing relevantly in important confounding factors. Since the number of females without an adequate match was already substantial when using 1:1 matching, we decided against a more flexible form of matching, e.g. 1:2 or 1:3, as the number of unmatched females would have been substantially increased.</p>
<p>Our data are based on patient recruitment between 1996 and 2005. Both medical therapy and revascularization techniques are improving over time. Particularly, the use of drug eluting stents and dual antiplatelet therapy evolved since the initial recruitment. However, as far as these clinical advances are concerned, we can safely assume that at each time point, they would have been applied to female and male patients similarly. It is therefore not likely that clinical advances over study duration impacted on the mortality differences. Finally, the retrospective nature of the analysis of prospectively-collected data needs to be acknowledged.</p>
</sec>
</sec>
<sec id="sec019" sec-type="conclusions">
<title>Conclusion</title>
<p>In this study, a typical cohort of AMI survivors was investigated with focus on sex-specific mortality. After matching females with 1:1 corresponding males of the same age, LVEF, cardiovascular risk factors and revascularization therapy, sex differences in post AMI survival could not be fully eliminated, particularly during the first year after the infarction. This finding is rather surprising and of clinical relevance.</p>
<p>Remaining excess female mortality might be, at least partly, explained by different pathophysiology of CAD in females and reduced applicability of invasive therapeutic approaches. Non-clinical variables including quality of life, family status and negative psychosocial responses triggered by AMI have to be considered. Nevertheless, we believe that our findings should encourage physicians to attend female AMI survivors with increased attention to prevent worse outcome in the future. In particular, our results appear to suggest that female post-AMI patients should be followed more actively with more frequent clinical and psychological assessments and support during at least the first year after AMI.</p>
</sec>
<sec id="sec020">
<title>Supporting information</title>
<supplementary-material id="pone.0186783.s001" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pone.0186783.s001" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>Study raw data.</title>
<p>PtNo: Patient Number, AMI: acute myocardial infarction, SR: sinus rhythm, CKmax: maximal level of creatine kinase, LVEF: left ventricular ejection fraction, CAD: coronary artery disease, ASS: acetylsalicylic acid, ACE_inhibitors: angiotensin-converting enzyme inhibitor, CSE_inhibitors: cholesterol synthesis enzyme inhibitor, fup_time: follow-up time.</p>
<p>(XLSX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>We would like to thank the authors and conductors of the ISAR-Risk and ART-study for kindly allowing us access to their data; namely Axel Bauer, Raphael Schneider, Kurt Ulm, Anke Joeinig, Raphael Stich, Antti Kiviniemi, Heikki Huikuri, Albert Schömig, Jørgen K. Kanters, Vijayapraveena Paruchuri, Xiaoyun Yang. Also, we thank Anna Berkefeld, Daniel Sinnecker and Michael Dommasch for providing critical comments on the study.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0186783.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bucholz</surname> <given-names>EM</given-names></name>, <name name-style="western"><surname>Butala</surname> <given-names>NM</given-names></name>, <name name-style="western"><surname>Rathore</surname> <given-names>SS</given-names></name>, <name name-style="western"><surname>Dreyer</surname> <given-names>RP</given-names></name>, <name name-style="western"><surname>Lansky</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Krumholz</surname> <given-names>HM</given-names></name>. <article-title>Sex differences in long-term mortality after myocardial infarction: a systematic review</article-title>. <source>Circulation</source>. <year>2014</year>;<volume>130</volume>(<issue>9</issue>):<fpage>757</fpage>–<lpage>67</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/CIRCULATIONAHA.114.009480" xlink:type="simple">10.1161/CIRCULATIONAHA.114.009480</ext-link></comment> <object-id pub-id-type="pmid">25052403</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wijnbergen</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Tijssen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>van 't Veer</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Michels</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Pijls</surname> <given-names>NH</given-names></name>. <article-title>Gender differences in long-term outcome after primary percutaneous intervention for ST-segment elevation myocardial infarction</article-title>. <source>Catheter Cardiovasc Interv</source>. <year>2013</year>;<volume>82</volume>(<issue>3</issue>):<fpage>379</fpage>–<lpage>84</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ccd.24800" xlink:type="simple">10.1002/ccd.24800</ext-link></comment> <object-id pub-id-type="pmid">23553888</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ciambrone</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Kaski</surname> <given-names>JC</given-names></name>. <article-title>The importance of gender differences in the diagnosis and management of cardiovascular disease</article-title>. <source>Curr Pharm Des</source>. <year>2011</year>;<volume>17</volume>(<issue>11</issue>):<fpage>1079</fpage>–<lpage>81</lpage>. <object-id pub-id-type="pmid">21449887</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Otten</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Maas</surname> <given-names>AH</given-names></name>, <name name-style="western"><surname>Ottervanger</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Kloosterman</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>van 't Hof</surname> <given-names>AW</given-names></name>, <name name-style="western"><surname>Dambrink</surname> <given-names>JH</given-names></name>, <etal>et al</etal>. <article-title>Is the difference in outcome between men and women treated by primary percutaneous coronary intervention age dependent? Gender difference in STEMI stratified on age</article-title>. <source>Eur Heart J Acute Cardiovasc Care</source>. <year>2013</year>;<volume>2</volume>(<issue>4</issue>):<fpage>334</fpage>–<lpage>41</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1177/2048872612475270" xlink:type="simple">10.1177/2048872612475270</ext-link></comment> <object-id pub-id-type="pmid">24338292</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Eitel</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Desch</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>de Waha</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Fuernau</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Gutberlet</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Schuler</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Sex differences in myocardial salvage and clinical outcome in patients with acute reperfused ST-elevation myocardial infarction: advances in cardiovascular imaging</article-title>. <source>Circ Cardiovasc Imaging</source>. <year>2012</year>;<volume>5</volume>(<issue>1</issue>):<fpage>119</fpage>–<lpage>26</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/CIRCIMAGING.111.965467" xlink:type="simple">10.1161/CIRCIMAGING.111.965467</ext-link></comment> <object-id pub-id-type="pmid">22028459</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Blomkalns</surname> <given-names>AL</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>AY</given-names></name>, <name name-style="western"><surname>Hochman</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Peterson</surname> <given-names>ED</given-names></name>, <name name-style="western"><surname>Trynosky</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Diercks</surname> <given-names>DB</given-names></name>, <etal>et al</etal>. <article-title>Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative</article-title>. <source>J Am Coll Cardiol</source>. <year>2005</year>;<volume>45</volume>(<issue>6</issue>):<fpage>832</fpage>–<lpage>37</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jacc.2004.11.055" xlink:type="simple">10.1016/j.jacc.2004.11.055</ext-link></comment> <object-id pub-id-type="pmid">15766815</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lerner</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Kannel</surname> <given-names>WB</given-names></name>. <article-title>Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population</article-title>. <source>Am Heart J</source>. <year>1986</year>;<volume>111</volume>:<fpage>383</fpage>–<lpage>90</lpage>. <object-id pub-id-type="pmid">3946178</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shaw</surname> <given-names>LJ</given-names></name>, <name name-style="western"><surname>Bairey Merz</surname> <given-names>CN</given-names></name>, <name name-style="western"><surname>Pepine</surname> <given-names>CJ</given-names></name>, <name name-style="western"><surname>Reis</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Bittner</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Kelsey</surname> <given-names>SF</given-names></name>, <etal>et al</etal>. <article-title>Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies</article-title>. <source>J Am Coll Cardiol</source>. <year>2006</year>;<volume>47</volume>(<issue>3 Suppl</issue>):<fpage>S4</fpage>–<lpage>S20</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jacc.2005.01.072" xlink:type="simple">10.1016/j.jacc.2005.01.072</ext-link></comment> <object-id pub-id-type="pmid">16458170</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leuzzi</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Sangiorgi</surname> <given-names>GM</given-names></name>, <name name-style="western"><surname>Modena</surname> <given-names>MG</given-names></name>. <article-title>Gender-specific aspects in the clinical presentation of cardiovascular disease</article-title>. <source>Fundam Clin Pharmacol</source>. <year>2010</year>;<volume>24</volume>(<issue>6</issue>):<fpage>711</fpage>–<lpage>17</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1472-8206.2010.00873.x" xlink:type="simple">10.1111/j.1472-8206.2010.00873.x</ext-link></comment> <object-id pub-id-type="pmid">20840353</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shin</surname> <given-names>JY</given-names></name>, <name name-style="western"><surname>Martin</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Suls</surname> <given-names>J</given-names></name>. <article-title>Meta-analytic evaluation of gender differences and symptom measurement strategies in acute coronary syndromes</article-title>. <source>Heart Lung</source>. <year>2010</year>;<volume>39</volume>(<issue>4</issue>):<fpage>283</fpage>–<lpage>95</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.hrtlng.2009.10.010" xlink:type="simple">10.1016/j.hrtlng.2009.10.010</ext-link></comment> <object-id pub-id-type="pmid">20561858</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Woods</surname> <given-names>SL</given-names></name>, <name name-style="western"><surname>Wilkie</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Puntillo</surname> <given-names>KA</given-names></name>. <article-title>Gender differences in symptom experiences of patients with acute coronary syndromes</article-title>. <source>J Pain Symptom Manage</source>. <year>2005</year>;<volume>30</volume>(<issue>6</issue>):<fpage>553</fpage>–<lpage>62</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jpainsymman.2005.06.004" xlink:type="simple">10.1016/j.jpainsymman.2005.06.004</ext-link></comment> <object-id pub-id-type="pmid">16376742</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cenko</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Bugiardini</surname> <given-names>R</given-names></name>. <article-title>Vasotonic Angina as a Cause of Myocardial Ischemia in Women</article-title>. <source>Cardiovasc Drugs Ther</source>. <year>2015</year>;<volume>29</volume>(<issue>4</issue>):<fpage>339</fpage>–<lpage>45</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10557-015-6595-4" xlink:type="simple">10.1007/s10557-015-6595-4</ext-link></comment> <object-id pub-id-type="pmid">26017335</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pepine</surname> <given-names>CJ</given-names></name>, <name name-style="western"><surname>Ferdinand</surname> <given-names>KC</given-names></name>, <name name-style="western"><surname>Shaw</surname> <given-names>LJ</given-names></name>, <name name-style="western"><surname>Light-McGroary</surname> <given-names>KA</given-names></name>, <name name-style="western"><surname>Shah</surname> <given-names>RU</given-names></name>, <name name-style="western"><surname>Gulati</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Emergence of Nonobstructive Coronary Artery Disease: A Woman's Problem and Need for Change in Definition on Angiography</article-title>. <source>J Am Coll Cardiol</source>. <year>2015</year>;<volume>66</volume>(<issue>17</issue>):<fpage>1918</fpage>–<lpage>33</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jacc.2015.08.876" xlink:type="simple">10.1016/j.jacc.2015.08.876</ext-link></comment> <object-id pub-id-type="pmid">26493665</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bugiardini</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Bairey Merz</surname> <given-names>CN</given-names></name>. <article-title>Angina with "normal" coronary arteries: a changing philosophy</article-title>. <source>JAMA</source>. <year>2005</year>;<volume>293</volume>(<issue>4</issue>):<fpage>477</fpage>–<lpage>84</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1001/jama.293.4.477" xlink:type="simple">10.1001/jama.293.4.477</ext-link></comment> <object-id pub-id-type="pmid">15671433</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shaw</surname> <given-names>LJ</given-names></name>, <name name-style="western"><surname>Bugiardini</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Merz</surname> <given-names>CN</given-names></name>. <article-title>Women and ischemic heart disease: evolving knowledge</article-title>. <source>J Am Coll Cardiol</source>. <year>2009</year>;<volume>54</volume>(<issue>17</issue>):<fpage>1561</fpage>–<lpage>75</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jacc.2009.04.098" xlink:type="simple">10.1016/j.jacc.2009.04.098</ext-link></comment> <object-id pub-id-type="pmid">19833255</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bugiardini</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Manfrini</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Pizzi</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Fontana</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Morgagni</surname> <given-names>G</given-names></name>. <article-title>Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms</article-title>. <source>Circulation</source>. <year>2004</year>;<volume>109</volume>(<issue>21</issue>):<fpage>2518</fpage>–<lpage>23</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/01.CIR.0000128208.22378.E3" xlink:type="simple">10.1161/01.CIR.0000128208.22378.E3</ext-link></comment> <object-id pub-id-type="pmid">15136498</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bauer</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Barthel</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Schneider</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Ulm</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Müller</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Joeinig</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Improved stratification of autonomic regulation for risk prediction in post-infarction patients with preserved left ventricular ejection fraction (ISAR-Risk)</article-title>. <source>Eur Heart J</source> <year>2009</year>;<volume>30</volume>:<fpage>576</fpage>–<lpage>83</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/eurheartj/ehn540" xlink:type="simple">10.1093/eurheartj/ehn540</ext-link></comment> <object-id pub-id-type="pmid">19109245</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barthel</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Bauer</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Müller</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Huster</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Kanters</surname> <given-names>JK</given-names></name>, <name name-style="western"><surname>Paruchuri</surname> <given-names>V</given-names></name>, <etal>et al</etal>. <article-title>Spontaneous baroreflex sensitivity: prospective validation trial of a novel technique in survivors of acute myocardial infarction</article-title>. <source>Heart Rhythm</source> <year>2012</year>;<volume>8</volume>:<fpage>1288</fpage>–<lpage>94</lpage>.</mixed-citation></ref>
<ref id="pone.0186783.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barthel</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Schneider</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Bauer</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ulm</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Schmitt</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Schömig</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Risk stratification after acute myocardial infarction by heart rate turbulence</article-title>. <source>Circulation</source>. <year>2003</year>;<volume>108</volume>(<issue>10</issue>):<fpage>1221</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/01.CIR.0000088783.34082.89" xlink:type="simple">10.1161/01.CIR.0000088783.34082.89</ext-link></comment> <object-id pub-id-type="pmid">12939209</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sinnecker</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Dommasch</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Steger</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Berkefeld</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Hoppmann</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Müller</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Expiration-Triggered Sinus Arrhythmia Predicts Outcome in Survivors of Acute Myocardial Infarction</article-title>. <source>J Am Coll Cardiol</source>. <year>2016</year> <month>May</month> <day>17</day>;<volume>67</volume>(<issue>19</issue>):<fpage>2213</fpage>–<lpage>20</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jacc.2016.03.484" xlink:type="simple">10.1016/j.jacc.2016.03.484</ext-link></comment> <object-id pub-id-type="pmid">27173032</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sinnecker</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Dirschinger</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>Barthel</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Müller</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Morley-Davies</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Hapfelmeier</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Postextrasystolic blood pressure potentiation predicts poor outcome of cardiac patients</article-title>. <source>J Am Heart Assoc</source>. <year>2014</year>; <volume>3</volume>(<issue>3</issue>):<fpage>e000857</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/JAHA.114.000857" xlink:type="simple">10.1161/JAHA.114.000857</ext-link></comment> <object-id pub-id-type="pmid">24895163</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rizas</surname> <given-names>KD</given-names></name>, <name name-style="western"><surname>Nieminen</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Barthel</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Zürn</surname> <given-names>CS</given-names></name>, <name name-style="western"><surname>Kähönen</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Viik</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Sympathetic activity-associated periodic repolarization dynamics predict mortality following myocardial infarction</article-title>. <source>J Clin Invest</source>. <year>2014</year>;<volume>124</volume>(<issue>4</issue>):<fpage>1770</fpage>–<lpage>80</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1172/JCI70085" xlink:type="simple">10.1172/JCI70085</ext-link></comment> <object-id pub-id-type="pmid">24642467</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barthel</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Wensel</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Bauer</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Müller</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Wolf</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Ulm</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Huster</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Francis</surname> <given-names>DP</given-names></name>, <name name-style="western"><surname>Malik</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Schmidt</surname> <given-names>G</given-names></name>. <article-title>Respiratory rate predicts outcome after acute myocardial infarction: a prospective cohort study</article-title>. <source>Eur Heart J</source>. <year>2013</year> <month>Jun</month>;<volume>34</volume>(<issue>22</issue>):<fpage>1644</fpage>–<lpage>50</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/eurheartj/ehs420" xlink:type="simple">10.1093/eurheartj/ehs420</ext-link></comment> <object-id pub-id-type="pmid">23242188</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barthel</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Bauer</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Müller</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Huster</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Kanters</surname> <given-names>JK</given-names></name>, <name name-style="western"><surname>Paruchuri</surname> <given-names>V</given-names></name>, <etal>et al</etal>. <article-title>Spontaneous baroreflex sensitivity: prospective validation trial of a novel technique in survivors of acute myocardial infarction</article-title>. <source>Heart Rhythm</source>. <year>2012</year>;<volume>9</volume>(<issue>8</issue>):<fpage>1288</fpage>–<lpage>94</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.hrthm.2012.04.017" xlink:type="simple">10.1016/j.hrthm.2012.04.017</ext-link></comment> <object-id pub-id-type="pmid">22516186</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>King</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Zeng</surname> <given-names>L</given-names></name>. <article-title>The danger of extreme counterfactuals</article-title>. <source>Political Analysis</source> <year>2006</year>; <volume>14</volume>(<issue>2</issue>):<fpage>131</fpage>–<lpage>59</lpage>.</mixed-citation></ref>
<ref id="pone.0186783.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rosenbaum</surname> <given-names>PR</given-names></name>, <name name-style="western"><surname>Rubin</surname> <given-names>DB</given-names></name>. <article-title>The central role of the propensity score in observational studies for causal effects</article-title>. <source>Biometrika</source>. <year>1983</year>;<volume>70</volume>:<fpage>41</fpage>–<lpage>55</lpage>.</mixed-citation></ref>
<ref id="pone.0186783.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ho</surname> <given-names>DE</given-names></name>, <name name-style="western"><surname>Imai</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>King</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Stuart</surname> <given-names>EA</given-names></name>. <article-title>MatchIt: Nonparametric Preprocessing for Parametric Causal Inference</article-title>. <source>J Stat Softw</source>. <year>2011</year>; <volume>42</volume>(<issue>8</issue>):<fpage>1</fpage>–<lpage>28</lpage>.</mixed-citation></ref>
<ref id="pone.0186783.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yu</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Mehran</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Grinfeld</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Xu</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Nikolsky</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Brodie</surname> <given-names>BR</given-names></name>, <etal>et al</etal>. <article-title>Sex-based differences in bleeding and long term adverse events after percutaneous coronary intervention for acute myocardial infarction: three year results from the HORIZONS-AMI trial</article-title>. <source>Catheter Cardiovasc Interv</source>. <year>2015</year>;<volume>85</volume>(<issue>3</issue>):<fpage>359</fpage>–<lpage>68</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ccd.25630" xlink:type="simple">10.1002/ccd.25630</ext-link></comment> <object-id pub-id-type="pmid">25115966</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Birkemeyer</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Schneider</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Rillig</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ebeling</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Akin</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Kische</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Do gender differences in primary PCI mortality represent a different adherence to guideline recommended therapy? A multicenter observation</article-title>. <source>BMC Cardiovasc Disord</source>. <year>2014</year>;<volume>14</volume>:<fpage>71</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2261-14-71" xlink:type="simple">10.1186/1471-2261-14-71</ext-link></comment> <object-id pub-id-type="pmid">24893930</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chaudhry</surname> <given-names>SI</given-names></name>, <name name-style="western"><surname>Khan</surname> <given-names>RF</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Dharmarajan</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Dodson</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Masoudi</surname> <given-names>FA</given-names></name>, <etal>et al</etal>. <article-title>National trends in recurrent AMI hospitalizations 1 year after acute myocardial infarction in Medicare beneficiaries: 1999–2010</article-title>. <source>J Am Heart Assoc</source>. <year>2014</year>;<volume>3</volume>(<issue>5</issue>):<fpage>e001197</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/JAHA.114.001197" xlink:type="simple">10.1161/JAHA.114.001197</ext-link></comment> <object-id pub-id-type="pmid">25249298</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Anderson</surname> <given-names>ML</given-names></name>, <name name-style="western"><surname>Peterson</surname> <given-names>ED</given-names></name>, <name name-style="western"><surname>Brennan</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Rao</surname> <given-names>SV</given-names></name>, <name name-style="western"><surname>Dai</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Anstrom</surname> <given-names>KJ</given-names></name>, <etal>et al</etal>. <article-title>Short- and long-term outcomes of coronary stenting in women versus men: results from the National Cardiovascular Data Registry Centers for Medicare &amp; Medicaid services cohort</article-title>. <source>Circulation</source>. <year>2012</year>;<volume>126</volume>(<issue>18</issue>):<fpage>2190</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/CIRCULATIONAHA.112.111369" xlink:type="simple">10.1161/CIRCULATIONAHA.112.111369</ext-link></comment> <object-id pub-id-type="pmid">22988009</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Skelding</surname> <given-names>KA</given-names></name>, <name name-style="western"><surname>Boga</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Sartorius</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Wood</surname> <given-names>GC</given-names></name>, <name name-style="western"><surname>Berger</surname> <given-names>PB</given-names></name>, <name name-style="western"><surname>Mascarenhas</surname> <given-names>VH</given-names></name>, <etal>et al</etal>. <article-title>Frequency of coronary angiography and revascularization among men and women with myocardial infarction and their relationship to mortality at one year: an analysis of the Geisinger myocardial infarction cohort</article-title>. <source>J Interv Cardiol</source>. <year>2013</year>;<volume>26</volume>(<issue>1</issue>):<fpage>14</fpage>–<lpage>21</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/joic.12009" xlink:type="simple">10.1111/joic.12009</ext-link></comment> <object-id pub-id-type="pmid">23278363</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sulzgruber</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Koller</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Pavo</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>El-Hamid</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Rothgerber</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Forster</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Gender-related differences in elderly patients with myocardial infarction in a European Centre</article-title>. <source>Eur J Clin Invest</source>. <year>2016</year>;<volume>46</volume>(<issue>1</issue>):<fpage>60</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/eci.12567" xlink:type="simple">10.1111/eci.12567</ext-link></comment> <object-id pub-id-type="pmid">26575703</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>D'Onofrio</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Safdar</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Lichtman</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Strait</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Dreyer</surname> <given-names>RP</given-names></name>, <name name-style="western"><surname>Geda</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Sex differences in reperfusion in young patients with ST-segment-elevation myocardial infarction: results from the VIRGO study</article-title>. <source>Circulation</source>. <year>2015</year>;<volume>131</volume>(<issue>15</issue>):<fpage>1324</fpage>–<lpage>32</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/CIRCULATIONAHA.114.012293" xlink:type="simple">10.1161/CIRCULATIONAHA.114.012293</ext-link></comment> <object-id pub-id-type="pmid">25792558</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hvelplund</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Galatius</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Madsen</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sørensen</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Madsen</surname> <given-names>JK</given-names></name>, <name name-style="western"><surname>Iversen</surname> <given-names>AZ</given-names></name>, <etal>et al</etal>. <article-title>Significance of the invasive strategy after acute myocardial infarction on prognosis and secondary preventive medication: a nationwide study of 6364 women and 11,915 men</article-title>. <source>J Invasive Cardiol</source>. <year>2012</year>;<volume>24</volume>(<issue>1</issue>):<fpage>19</fpage>–<lpage>24</lpage>. <object-id pub-id-type="pmid">22210585</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Poon</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Goodman</surname> <given-names>SG</given-names></name>, <name name-style="western"><surname>Yan</surname> <given-names>RT</given-names></name>, <name name-style="western"><surname>Bugiardini</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Bierman</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Eagle</surname> <given-names>KA</given-names></name>, <etal>et al</etal>. <article-title>Bridging the gender gap: Insights from a contemporary analysis of sex-related differences in the treatment and outcomes of patients with acute coronary syndromes</article-title>. <source>Am Heart J</source>. <year>2012</year>;<volume>163</volume>(<issue>1</issue>):<fpage>66</fpage>–<lpage>73</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ahj.2011.09.025" xlink:type="simple">10.1016/j.ahj.2011.09.025</ext-link></comment> <object-id pub-id-type="pmid">22172438</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lam</surname> <given-names>CS</given-names></name>, <name name-style="western"><surname>McEntegart</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Claggett</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Skali</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Lewis</surname> <given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Sex differences in clinical characteristics and outcomes after myocardial infarction: insights from the Valsartan in Acute Myocardial Infarction Trial (VALIANT)</article-title>. <source>Eur J Heart Fail</source>. <year>2015</year>;<volume>17</volume>(<issue>3</issue>):<fpage>301</fpage>–<lpage>12</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ejhf.238" xlink:type="simple">10.1002/ejhf.238</ext-link></comment> <object-id pub-id-type="pmid">25655011</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dreyer</surname> <given-names>RP</given-names></name>, <name name-style="western"><surname>Beltrame</surname> <given-names>JF</given-names></name>, <name name-style="western"><surname>Tavella</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Air</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Hoffmann</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Pati</surname> <given-names>PK</given-names></name>, <etal>et al</etal>. <article-title>Evaluation of gender differences in Door-to-Balloon time in ST-elevation myocardial infarction</article-title>. <source>Heart Lung Circ</source>. <year>2013</year>;<volume>22</volume>(<issue>10</issue>):<fpage>861</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.hlc.2013.03.078" xlink:type="simple">10.1016/j.hlc.2013.03.078</ext-link></comment> <object-id pub-id-type="pmid">23628331</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hudson</surname> <given-names>MP</given-names></name>, <name name-style="western"><surname>Armstrong</surname> <given-names>PW</given-names></name>, <name name-style="western"><surname>O'Neil</surname> <given-names>WW</given-names></name>, <name name-style="western"><surname>Stebbins</surname> <given-names>AL</given-names></name>, <name name-style="western"><surname>Weaver</surname> <given-names>WD</given-names></name>, <name name-style="western"><surname>Widimsky</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial</article-title>. <source>Circ Cardiovasc Qual Outcomes</source>. <year>2011</year>;<volume>4</volume>(<issue>2</issue>):<fpage>183</fpage>–<lpage>92</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/CIRCOUTCOMES.110.945311" xlink:type="simple">10.1161/CIRCOUTCOMES.110.945311</ext-link></comment> <object-id pub-id-type="pmid">21304097</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rathore</surname> <given-names>SS</given-names></name>, <name name-style="western"><surname>Curtis</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Nallamothu</surname> <given-names>BK</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Foody</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Kosiborod</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Association of door-to-balloon time and mortality in patients &gt; or = 65 years with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention</article-title>. <source>Am J Cardiol</source>. <year>2009</year>;<volume>104</volume>(<issue>9</issue>):<fpage>1198</fpage>–<lpage>203</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.amjcard.2009.06.034" xlink:type="simple">10.1016/j.amjcard.2009.06.034</ext-link></comment> <object-id pub-id-type="pmid">19840562</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Choi</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Kang</surname> <given-names>YU</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>CS</given-names></name>, <name name-style="western"><surname>Bae</surname> <given-names>EH</given-names></name>, <name name-style="western"><surname>Ma</surname> <given-names>SK</given-names></name>, <etal>et al</etal>. <article-title>Does gender influence the impact of impaired renal function on prognosis after ST-segment elevated myocardial infarction?</article-title> <source>Cardiol J</source>. <year>2013</year>;<volume>20</volume>(<issue>5</issue>):<fpage>526</fpage>–<lpage>32</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5603/CJ.2013.0138" xlink:type="simple">10.5603/CJ.2013.0138</ext-link></comment> <object-id pub-id-type="pmid">24469877</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gevaert</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>De Bacquer</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Evrard</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Renard</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Beauloye</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Coussement</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Renal dysfunction in STEMI-patients undergoing primary angioplasty: higher prevalence but equal prognostic impact in female patients; an observational cohort study from the Belgian STEMI registry</article-title>. <source>BMC Nephrol</source>. <year>2013</year>;<volume>14</volume>:<fpage>62</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2369-14-62" xlink:type="simple">10.1186/1471-2369-14-62</ext-link></comment> <object-id pub-id-type="pmid">23506004</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Alter</surname> <given-names>DA</given-names></name>, <name name-style="western"><surname>Franklin</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Ko</surname> <given-names>DT</given-names></name>, <name name-style="western"><surname>Austin</surname> <given-names>PC</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>DS</given-names></name>, <name name-style="western"><surname>Oh</surname> <given-names>PI</given-names></name>, <etal>et al</etal>. <article-title>Socioeconomic status, functional recovery, and long-term mortality among patients surviving acute myocardial infarction</article-title>. <source>PLoS One</source>. <year>2013</year>;<volume>8</volume>(<issue>6</issue>):<fpage>e65130</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0065130" xlink:type="simple">10.1371/journal.pone.0065130</ext-link></comment> <object-id pub-id-type="pmid">23755180</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wheeler</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Beltrame</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Tucker</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Air</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Ling</surname> <given-names>LH</given-names></name>, <name name-style="western"><surname>Schrader</surname> <given-names>G</given-names></name>. <article-title>Depression and 5-year mortality in patients with acute myocardial infarction: analysis of the IDACC database</article-title>. <source>Aust N Z J Psychiatry</source>. <year>2012</year>; <volume>46</volume>(<issue>7</issue>):<fpage>669</fpage>–<lpage>75</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1177/0004867412449875" xlink:type="simple">10.1177/0004867412449875</ext-link></comment> <object-id pub-id-type="pmid">22645397</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Grunau</surname> <given-names>GL</given-names></name>, <name name-style="western"><surname>Ratner</surname> <given-names>PA</given-names></name>, <name name-style="western"><surname>Goldner</surname> <given-names>EM</given-names></name>, <name name-style="western"><surname>Sheps</surname> <given-names>S</given-names></name>. <article-title>Is early- and late-onset depression after acute myocardial infarction associated with long-term survival in older adults? A population-based study</article-title>. <source>Can J Cardiol</source>. <year>2006</year>;<volume>22</volume>(<issue>6</issue>):<fpage>473</fpage>–<lpage>8</lpage>. <object-id pub-id-type="pmid">16685310</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dreyer</surname> <given-names>RP</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Strait</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Lorenze</surname> <given-names>NP</given-names></name>, <name name-style="western"><surname>D'Onofrio</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Bueno</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Gender differences in the trajectory of recovery in health status among young patients with acute myocardial infarction: results from the variation in recovery: role of gender on outcomes of young AMI patients (VIRGO) study</article-title>. <source>Circulation</source>. <year>2015</year>;<volume>131</volume>(<issue>22</issue>):<fpage>1971</fpage>–<lpage>80</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/CIRCULATIONAHA.114.014503" xlink:type="simple">10.1161/CIRCULATIONAHA.114.014503</ext-link></comment> <object-id pub-id-type="pmid">25862743</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dodson</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Arnold</surname> <given-names>SV</given-names></name>, <name name-style="western"><surname>Reid</surname> <given-names>KJ</given-names></name>, <name name-style="western"><surname>Gill</surname> <given-names>TM</given-names></name>, <name name-style="western"><surname>Rich</surname> <given-names>MW</given-names></name>, <name name-style="western"><surname>Masoudi</surname> <given-names>FA</given-names></name>, <etal>et al</etal>. <article-title>Physical function and independence 1 year after myocardial infarction: observations from the Translational Research Investigating Underlying Disparities in Recovery From Acute Myocardial Infarction: Patients’ Health Status Registry</article-title>. <source>Am Heart J</source>. <year>2012</year>;<volume>163</volume>:<fpage>790</fpage>–<lpage>96</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ahj.2012.02.024" xlink:type="simple">10.1016/j.ahj.2012.02.024</ext-link></comment> <object-id pub-id-type="pmid">22607856</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leung Yinko</surname> <given-names>SS</given-names></name>, <name name-style="western"><surname>Pelletier</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Behlouli</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Norris</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>Humphries</surname> <given-names>KH</given-names></name>, <name name-style="western"><surname>Pilote</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Health-related quality of life in premature acute coronary syndrome: does patient sex or gender really matter?</article-title> <source>J Am Heart Assoc</source>. <year>2014</year>;<volume>3</volume>(<issue>4</issue>). pii:<fpage>e000901</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/JAHA.114.000901" xlink:type="simple">10.1161/JAHA.114.000901</ext-link></comment> <object-id pub-id-type="pmid">25074696</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref049"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brink</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Grankvist</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Karlson</surname> <given-names>BW</given-names></name>, <name name-style="western"><surname>Hallberg</surname> <given-names>LR</given-names></name>. <article-title>Health-related quality of life in women and men one year after acute myocardial infarction</article-title>. <source>Qual Life Res</source>. <year>2005</year>;<volume>14</volume>:<fpage>749</fpage>–<lpage>57</lpage>. <object-id pub-id-type="pmid">16022067</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref050"><label>50</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Emery</surname> <given-names>CF</given-names></name>, <name name-style="western"><surname>Frid</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Engebretson</surname> <given-names>TO</given-names></name>, <name name-style="western"><surname>Alonzo</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>Fish</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ferketich</surname> <given-names>AK</given-names></name>, <etal>et al</etal>. <article-title>Gender differences in quality of life among cardiac patients</article-title>. <source>Psychosom Med</source>. <year>2004</year>;<volume>66</volume>:<fpage>190</fpage>–<lpage>7</lpage>. <object-id pub-id-type="pmid">15039503</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref051"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Beck</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Joseph</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Bélisle</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Pilote</surname> <given-names>L</given-names></name>; <collab>QOLAMI Investigators (Quality of life in acute myocardial infarction)</collab>, <etal>et al</etal>. <article-title>Predictors of quality of life 6 months and 1 year after acute myocardial infarction</article-title>. <source>Am Heart J</source>. <year>2001</year>;<volume>142</volume>:<fpage>271</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1067/mhj.2001.116758" xlink:type="simple">10.1067/mhj.2001.116758</ext-link></comment> <object-id pub-id-type="pmid">11479466</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref052"><label>52</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cossette</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Frasure-Smith</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Lespérance</surname> <given-names>F</given-names></name>. <article-title>Clinical implications of a reduction in psychological distress on cardiac prognosis in patients participating in a psychosocial intervention program</article-title>. <source>Psychosom Med</source>. <year>2001</year>;<volume>63</volume>(<issue>2</issue>):<fpage>257</fpage>–<lpage>66</lpage>. <object-id pub-id-type="pmid">11292273</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref053"><label>53</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Norris</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>Hegadoren</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Pilote</surname> <given-names>L</given-names></name>. <article-title>Depression symptoms have a greater impact on the 1-year health-related quality of life outcomes of women post-myocardial infarction compared to men</article-title>. <source>Eur J Cardiovasc Nurs</source>. <year>2007</year>;<volume>6</volume>(<issue>2</issue>):<fpage>92</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ejcnurse.2006.05.003" xlink:type="simple">10.1016/j.ejcnurse.2006.05.003</ext-link></comment> <object-id pub-id-type="pmid">16843729</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref054"><label>54</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Frasure-Smith</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Lespérance</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Juneau</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Talajic</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Bourassa</surname> <given-names>MG</given-names></name>. <article-title>Gender, depression, and one-year prognosis after myocardial infarction</article-title>. <source>Psychosom Med</source>. <year>1999</year>;<volume>61</volume>(<issue>1</issue>):<fpage>26</fpage>–<lpage>37</lpage>. <object-id pub-id-type="pmid">10024065</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref055"><label>55</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chandra</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Szklo</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Goldberg</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Tonascia</surname> <given-names>J</given-names></name>. <article-title>The impact of marital status on survival after an acute myocardial infarction: a population-based study</article-title>. <source>Am J Epidemiol</source>. <year>1983</year>;<volume>117</volume>:<fpage>320</fpage>–<lpage>5</lpage>. <object-id pub-id-type="pmid">6829559</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref056"><label>56</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kilpi</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Konttinen</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Silventoinen</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Martikainen</surname> <given-names>P</given-names></name>. <article-title>Living arrangements as determinants of myocardial infarction incidence and survival: A prospective register study of over 300,000 Finnish men and women</article-title>. <source>Soc Sci Med</source>. <year>2015</year>;<volume>133</volume>:<fpage>93</fpage>–<lpage>100</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.socscimed.2015.03.054" xlink:type="simple">10.1016/j.socscimed.2015.03.054</ext-link></comment> <object-id pub-id-type="pmid">25863724</object-id></mixed-citation></ref>
<ref id="pone.0186783.ref057"><label>57</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ubrich</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Barthel</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Berkefeld</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Hnatkova</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Huster</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Dommasch</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Electrocardiographic and cardiac autonomic indices—implications of sex-specific risk stratification in women after acute myocardial infarction</article-title>. <source>Curr Pharm Des</source>. <year>2016</year>;<volume>22</volume>(<issue>25</issue>):<fpage>3817</fpage>–<lpage>28</lpage>. <object-id pub-id-type="pmid">26965489</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>